Varicella-zoster virus: Prevention through vaccination

Clin Obstet Gynecol. 2012 Jun;55(2):560-70. doi: 10.1097/GRF.0b013e3182510b67.

Abstract

Widespread use of varicella vaccine in the United States has drastically changed the epidemiology of the disease. Although chickenpox is no longer a ubiquitous childhood infection, varicella-zoster virus continues to circulate in the community and nonimmune pregnant women remain at risk. Varicella can cause severe infection in pregnant women, often complicated by viral pneumonia. Maternal varicella occurring in the first half of pregnancy can cause the rare but devastating congenital varicella syndrome, whereas infection in the late stages of pregnancy may cause neonatal varicella. The best approach to avoiding the morbidity and mortality associated with chickenpox in pregnancy is to screen and vaccinate susceptible reproductive-age women.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Acyclovir / therapeutic use
  • Antiviral Agents / therapeutic use
  • Chemoprevention
  • Chickenpox / congenital
  • Chickenpox / diagnosis
  • Chickenpox / drug therapy
  • Chickenpox / prevention & control*
  • Chickenpox Vaccine*
  • Disease Susceptibility
  • Female
  • Herpes Zoster / drug therapy
  • Herpesvirus 3, Human / immunology
  • Humans
  • Immunization, Passive
  • Immunoglobulins / therapeutic use
  • Immunologic Factors / therapeutic use
  • Infant, Newborn
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / etiology
  • Postnatal Care
  • Preconception Care
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy
  • Pregnancy Complications, Infectious / etiology
  • Pregnancy Complications, Infectious / prevention & control*
  • Prenatal Care

Substances

  • Antiviral Agents
  • Chickenpox Vaccine
  • Immunoglobulins
  • Immunologic Factors
  • Acyclovir